Exyn Technologies grants 23,200 stock options
Exyn Technologies, Inc. director Ollwerther Jonathan Carey received a grant of stock options for 23,200 shares of common stock on August 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exyn Technologies, Inc. director Ollwerther Jonathan Carey received a grant of stock options for 23,200 shares of common stock on August 3, 2026. The options have an exercise price of $1.82 per share, expire on August 3, 2036, and vest one-third on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to continued service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 23,200 | $0.00 | $0.00 |
Footnotes (1)
- F1. On August 3, 2026 (the "Grant Date"), the Reporting Person was granted stock options to purchase 23,200 shares of the Issuer's common stock. These options vest in accordance with the following schedule: one-third of the shares on August 3, 2027 and one-third on each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Key Figures
Key Terms
Stock Option financial
exercise price financial
vesting financial
service provider financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Exyn Technologies (EXYN) report for Ollwerther Jonathan Carey?
What is the exercise price of the stock options granted by Exyn Technologies (EXYN)?
When do the Exyn Technologies (EXYN) stock options granted to Ollwerther Jonathan Carey vest?
What is the expiration date of the Exyn Technologies (EXYN) stock options granted on August 3, 2026?
AI-generated analysis. How Rhea-AI works. Not financial advice.